2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Daliresp (Roflumilast ... PDE4) Inhibitor GOLD ... 2019 Guideline ... GOLD guidelines ... /ambcarerx #Daliresp
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
Algorithm - GOLD ... 2019 guidelines ... GOLD 2019 guidelines ... #Guidelines #Management ... #Pulmonary #Algorithm